PL349341A1 - Imidazo[4,5-c]-pyridine-4-on-derivatives - Google Patents

Imidazo[4,5-c]-pyridine-4-on-derivatives

Info

Publication number
PL349341A1
PL349341A1 PL99349341A PL34934199A PL349341A1 PL 349341 A1 PL349341 A1 PL 349341A1 PL 99349341 A PL99349341 A PL 99349341A PL 34934199 A PL34934199 A PL 34934199A PL 349341 A1 PL349341 A1 PL 349341A1
Authority
PL
Poland
Prior art keywords
imidazo
pyridine
derivatives
Prior art date
Application number
PL99349341A
Other languages
English (en)
Inventor
Werner Mederski
Horst Juraszyk
Hanns Wurziger
Christos Tsaklakidis
Dieter Dorsch
Sabine Bernotat-Danielowski
Guido Melzer
Soheila Anzali
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL349341A1 publication Critical patent/PL349341A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL99349341A 1999-01-08 1999-12-21 Imidazo[4,5-c]-pyridine-4-on-derivatives PL349341A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900471A DE19900471A1 (de) 1999-01-08 1999-01-08 Imidazo[4,5c]-pyridin-4-on-derivate
PCT/EP1999/010236 WO2000040583A2 (de) 1999-01-08 1999-12-21 Imidazo[4,5-c]-pyridin-4-on-derivate

Publications (1)

Publication Number Publication Date
PL349341A1 true PL349341A1 (en) 2002-07-15

Family

ID=7893790

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99349341A PL349341A1 (en) 1999-01-08 1999-12-21 Imidazo[4,5-c]-pyridine-4-on-derivatives

Country Status (16)

Country Link
EP (1) EP1149099A2 (de)
JP (1) JP2002534429A (de)
KR (1) KR20010086085A (de)
CN (1) CN1333772A (de)
AR (1) AR022220A1 (de)
AU (1) AU3041700A (de)
BR (1) BR9916774A (de)
CA (1) CA2357771A1 (de)
CZ (1) CZ20012407A3 (de)
DE (1) DE19900471A1 (de)
HU (1) HUP0105054A3 (de)
NO (1) NO20013384D0 (de)
PL (1) PL349341A1 (de)
SK (1) SK9442001A3 (de)
WO (1) WO2000040583A2 (de)
ZA (1) ZA200106454B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2232202T3 (es) 1998-12-23 2005-05-16 Bristol-Myers Squibb Pharma Company Heterobiciclos que contienen nitrogeno como inhibidores del factor xa.
JP2004501918A (ja) 2000-06-23 2004-01-22 ブリストル−マイヤーズ　スクイブ　ファーマ　カンパニー Ｘａ因子阻害剤としての１−（ヘテロアリール−フェニル）−縮合ピラゾール誘導体
EP1414449A4 (de) 2001-05-22 2005-04-06 Bristol Myers Squibb Co Bizyklische faktor-xa-hemmer
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
GB0225399D0 (en) * 2002-10-31 2002-12-11 Merck Sharp & Dohme Therapeutic agents
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
PL1706403T3 (pl) 2003-12-22 2012-07-31 K U Leuven Res & Development Związki imidazo[4,5-c]pirydynowe i sposoby leczenia przeciwwirusowego
DE602005013580D1 (de) 2004-12-21 2009-05-07 Leuven K U Res & Dev Imidazoä4,5-cüpyridinverbindung und verfahren zur antiviralen behandlung
EP1907388A1 (de) * 2005-07-15 2008-04-09 F. Hoffmann-Roche AG Neue kondensierte cyclische heteroarylamine
DK1942898T4 (da) 2005-09-14 2014-06-02 Takeda Pharmaceutical Dipeptidylpeptidase-inhibitorer til behandling af diabetes
KR101368988B1 (ko) 2005-09-16 2014-02-28 다케다 야쿠힌 고교 가부시키가이샤 디펩티딜 펩티다제 억제제
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
TWI360549B (en) 2006-07-07 2012-03-21 Gilead Sciences Inc Novel pyridazine compound and use thereof
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
JP6689821B2 (ja) * 2014-08-12 2020-04-28 シンジェンタ パーティシペーションズ アーゲー 硫黄含有置換基を有する殺有害生物的に活性な複素環式誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW219935B (de) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
CA2309347A1 (en) * 1997-12-01 1999-06-10 Merck & Co., Inc. Thrombin inhibitors

Also Published As

Publication number Publication date
AU3041700A (en) 2000-07-24
NO20013384L (no) 2001-07-06
BR9916774A (pt) 2001-10-30
WO2000040583A3 (de) 2000-09-21
CA2357771A1 (en) 2000-07-13
DE19900471A1 (de) 2000-07-13
AR022220A1 (es) 2002-09-04
NO20013384D0 (no) 2001-07-06
CZ20012407A3 (cs) 2001-12-12
WO2000040583A2 (de) 2000-07-13
SK9442001A3 (en) 2002-05-09
KR20010086085A (ko) 2001-09-07
EP1149099A2 (de) 2001-10-31
CN1333772A (zh) 2002-01-30
HUP0105054A2 (hu) 2002-05-29
JP2002534429A (ja) 2002-10-15
HUP0105054A3 (en) 2002-12-28
ZA200106454B (en) 2002-11-06

Similar Documents

Publication Publication Date Title
AP1917A (en) Azaindoles
CZ20011556A3 (cs) Pyrazolopyridinové deriváty
PL353827A1 (en) 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i
IL140197A0 (en) β-CARBOLINE COMPOUNDS
PL354600A1 (en) Naphthyridine derivatives
TW526820U (en) Seat
PL349341A1 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives
PL349364A1 (en) Use of pyridazino[4,5-b
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
GB2355250B (en) Parallel-gripping chuck
SG79259A1 (en) Diaza-spiro[3,5]nonane deravatives
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
GB2352661B (en) Chuck
EP1170018A4 (de) Ligandgebundener komplex
GB0011191D0 (en) Chuck
GB9929094D0 (en) Robotics
PL352760A1 (en) Oxathiepino[6,5-b
ZA985559B (en) Tetrahydroimidazo Ä2,1-aÜsoquinoline derivatives
TW408673U (en) Multi-purpose industrual robot
PL325356A1 (en) Novel derivative 2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-5-carboxylic pyrolydinamide
CA87281S (en) Shower-batch seat
GB2352622B (en) Seat
GB2345961B (en) Autocalibration device
GB2368546B (en) Chuck
TW432998U (en) Armrest